CLINICAL_TRIALS
trial_result
· 2015-08-19
Clinical Trial Update: A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers [Phase 1]
Summary
Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of odanacatib (MK0822) in healthy volunteers.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED